CoChat

Epigenetics in Alzheimer’s Disease: Perspective of DNA Methylation

Qazi, Talal Jamil, Quan, Zhenzhen, Mir, Asif, Qing, Hong · 2018 · Molecular Neurobiology

The DOI matches its Crossref record; 195 of the 195 references it cites were found in a registry or an index.

Abstract

Research over the years has shown that causes of Alzheimer's disease are not well understood, but over the past years, the involvement of epigenetic mechanisms in the developing memory formation either under pathological or physiological conditions has become clear. The term epigenetics represents the heredity of changes in phenotype that are independent of altered DNA sequences. Different studies validated that cytosine methylation of genomic DNA decreases with age in different tissues of mammals, and therefore, the role of epigenetic factors in developing neurological disorders in aging has been under focus. In this review, we summarized and reviewed the involvement of different epigenetic mechanisms especially the DNA methylation in Alzheimer's disease (AD), late-onset Alzheimer's disease (LOAD), familial Alzheimer's disease (FAD), and autosomal dominant Alzheimer's disease (ADAD). Down to the minutest of details, we tried to discuss the methylation patterns like mitochondrial DNA methylation and ribosomal DNA (rDNA) methylation. Additionally, we mentioned some therapeutic approaches related to epigenetics, which could provide a potential cure for AD. Moreover, we reviewed some recent studies that validate DNA methylation as a potential biomarker and its role in AD. We hope that this review will provide new insights into the understanding of AD pathogenesis from the epigenetic perspective especially from the perspective of DNA methylation.

Overview

Integrity signals

Registry

Crossref · 10.1007/s12035-016-0357-6

Cites

195 of 195 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 195 references

Research works printed but not linked: 1

  1. van Emburgh BO, Robertson KD (2008) DNA methyltransferases and methyl-CpG binding proteins as multifunctional regulators of chromatin structure and development in mammalian cells. In: Tost J (ed) Epigenetics. Caister Academic Press, Norfolk, pp. 22–61

Cited by

See all 157

Metadata

Authors
Qazi, T. J., Quan, Z., Mir, A., & Qing, H.
Affiliations
  • Beijing Institute of Technology (CN)
  • International Islamic University, Islamabad (PK)
Corresponding author
Qing, Hong
Venue
Molecular Neurobiology
Published
2017-01-14
Volume
55
Issue
2
Pages
1026-1044
ISSN
  • 0893-7648 (ISSN-L)
  • 1559-1182
OpenAlex
W2572342044
Cited by
153
References
195
Citations by year
2026: 8 · 2025: 18 · 2024: 22 · 2023: 23 · 2022: 15 · 2021: 18 · 2020: 20 · 2019: 8 · 2018: 12 · 2017: 9
FWCI
1.26
Type
journal article
Language
en
Open access
closed
Locations
  • Molecular Neurobiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (81671268)
  • Ministry of Science and Technology of the People’s Republic of China (No. 2013YQ03059514)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, DNA methylation, epigenetics, late-onset Alzheimer's disease, familial Alzheimer's disease, autosomal dominant Alzheimer's disease, mitochondrial DNA methylation, aging, memory formation, epigenetic biomarkers, epigenetic therapy, Alzheimer's disease pathogenesis
MeSH terms
Alzheimer Disease, DNA, Mitochondrial, Humans, Mitochondria, DNA Methylation, Epigenesis, Genetic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epigenetics in Alzheimer’s Disease: Perspective of DNA Methylation. https://app.cochat.ai/papers/10.1007/s12035-016-0357-6
The paper
Qazi, T. J., Quan, Z., Mir, A., & Qing, H. (2018). Epigenetics in Alzheimer’s Disease: Perspective of DNA Methylation. Molecular Neurobiology. https://doi.org/10.1007/s12035-016-0357-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.